Study of Drug Resistance in Colon Cancer Cells
Author Information
Author(s): E Dolfini, T Dasdial, G Arancia, A Molinari, A Calcabrini, RJ Scheper, MJ Flens, MB Gariboldi, E Monti
Primary Institution: University of Milano
Hypothesis
The study aims to characterize a clonal human colon adenocarcinoma line that is intrinsically resistant to doxorubicin.
Conclusion
The study found that increased expression of MRP and alterations in drug distribution contribute to the intrinsic resistance of LoVo/C7 cells to doxorubicin.
Supporting Evidence
- LoVo/C7 cells showed increased expression of MRP, which is associated with drug resistance.
- Alterations in the subcellular distribution of doxorubicin were observed in LoVo/C7 cells.
- Changes in PKC isoform patterns were detected in both intrinsically and pharmacologically resistant cells.
Takeaway
Some colon cancer cells can resist treatment with a common drug called doxorubicin, and this study looked at why that happens.
Methodology
The study involved isolating two monoclonal lines from LoVo human colon adenocarcinoma cells and assessing various proteins related to drug resistance.
Limitations
The study primarily focuses on in vitro models, which may not fully represent in vivo conditions.
Statistical Information
P-Value
p<0.05
Statistical Significance
p<0.05
Want to read the original?
Access the complete publication on the publisher's website